SKAP2: A Potential Drug Target and Biomarker for src Kinase-Associated Phosphoprotein

Target Name: SKAP2

NCBI ID: G8935

SKAP2

SKAP2: A Potential Drug Target and Biomarker for src Kinase-Associated Phosphoprotein

SKAP2 (Src kinase-associated phosphoprotein of 55-related protein) is a protein that has been identified as a potential drug target and biomarker for src kinase, a protein that plays a critical role in cell signaling. SKAP2 is a 55kDa protein that is expressed in a variety of tissues, including muscle, heart, and brain. It is involved in several cellular processes, including cell signaling, DNA replication, and chromatin remodeling.

SKAP2 functions as a protein kinase, which means it can phosphorylate other proteins. Its phosphorylation sites are located near its active center, and these phosphorylation sites can interact with the phosphorylation of other proteins, resulting in protein phosphorylation modification. Phosphorylation modifications can affect protein structure, function, and interactions. Therefore, SKAP2 plays an important role in cell signaling, DNA replication, and chromatin remodeling.

The phosphorylation status of SKAP2 is closely related to src kinase activity. src kinase is a kinase that can phosphorylate many proteins, including SKAP2. When src kinase phosphorylates SKAP2, it phosphorylates the active center of SKAP2, causing changes in its phosphorylation state. This change in phosphorylation status can affect the cellular functions and interactions of SKAP2. Therefore, SKAP2 can serve as a substrate of src kinase and an inhibitor of src kinase, becoming a promising drug target.

SKAP2 can also be used as a potential biomarker for detecting src kinase activity. Since SKAP2 is a substrate of src kinase, when src kinase is present, it will be phosphorylated, resulting in changes in the phosphorylation status of SKAP2. Therefore, the activity of src kinase can be detected by measuring the phosphorylation status of SKAP2. This method can be used to study the role of src kinase in tumorigenesis and the effect of src kinase inhibitors in the treatment of tumors.

The phosphorylation status of SKAP2 is also closely related to the phosphorylation status of many other proteins. For example, the phosphorylation state of SKAP2 can be regulated by a variety of protein phosphorylases, including ATPase, HMG coenzyme A enzyme, and SIRT3. These protein phosphorylases can phosphorylate the active center of SKAP2, thereby affecting its phosphorylation status. Therefore, the phosphorylation status of SKAP2 can be used as an important indicator to study the function of protein phosphorylase.

In addition, the phosphorylation status of SKAP2 can also be used as an important indicator for studying cell metabolism and energy metabolism. SKAP2 plays an important role in cellular metabolism and energy metabolism and can participate in multiple metabolic pathways, including glycolysis, fatty acid metabolism, and cellular respiration. Therefore, the phosphorylation status of SKAP2 can be used as an important indicator to study cell metabolism and energy metabolism.

SKAP2 is a widely expressed protein that plays a role in multiple tissues and organs. It can be used as a drug target and as a potential biomarker for detecting src kinase activity. Further research can reveal the role of SKAP2 in cell signaling, DNA replication, chromatin remodeling and other processes, and provide new ideas and methods for the treatment of related diseases.

Protein Name: Src Kinase Associated Phosphoprotein 2

Functions: May be involved in B-cell and macrophage adhesion processes. In B-cells, may act by coupling the B-cell receptor (BCR) to integrin activation. May play a role in src signaling pathway

The "SKAP2 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about SKAP2 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets